Hologic, Inc. (Nasdaq: HOLX) announced today that Namal Nawana has been elected to the Company's Board of Directors, effective immediately.
Mr. Nawana, who has more than 20 years of global healthcare experience, was formerly the Chief Executive Officer of Alere, Inc., a publicly-traded global manufacturer of rapid point-of-care diagnostic tests that was acquired by Abbott Laboratories in October 2017. Before joining Alere, Mr. Nawana spent 15 years at Johnson & Johnson in various leadership roles, most recently as the Worldwide President of DePuy Synthes Spine.
"Namal is an excellent addition to Hologic's Board of Directors," said Steve MacMillan, the Company's Chairman, President and Chief Executive Officer. "His deep global experience in the industry as well as his operating expertise will be great complements to our current Board."
Mr. Nawana holds an Honors degree in mechanical engineering and a Master of Medical Science from the University of Adelaide, South Australia, and a Master of Business Administration from Henley Management College.
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.